A_Atrofi: New compounds for the treatment of musculoskeletal atrophy and cachexia

The invention is represented by a mixture of molecules, called A_ATROFI, capable of regulating the balance between protein synthesis and its degradation in skeletal muscle cells.

Settore:

Life sciences

Research Institution:

Università degli Studi di Firenze

Publication number:

WO2021024101A1

TRL:

4

Technologies, Systems, Applications:

New drugs development,
Biotechnologies

Technological Priority:

Biomedical, pharmaceutical, pharmacological technologies,
Biotechnologies for health
Pubblicato il: